source
- Women-led biotech M&A drops sharply in 2026, only two major deals recorded so farLast year saw an unprecedented wave of women-led biotech transactions, with eleven high‑value deals out of 72 total biopharma mergers in 2025. In 2026 the pace has slowed dramatically, with just…
- Biopharma must incentivize scientists to make early go-no-go decisionsThe article argues that simply urging scientists to think like entrepreneurs is not enough; biopharma firms need to align rewards with that mindset. Because only about one in ten drug candidates t…